“The apprehension with using non IID shown ingredients is justified as it is actually not possible to evaluate if FDA would locate the ‘novel excipient’ Harmless for use in the drug product as there is no described approach for evaluation and approval of excipients. The FDA guidance on ‘Nonclinical https://johng383zqf8.blogcudinti.com/26840096/getting-my-proleviate-includes-fda-approved-ingredients-to-work